Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Nov 24 | CAVA CAVA | Common Stock | Sell | Dispose S | No | No | 134.13 | 8,000,000 | 1.07 bn | 9,507,990 |
26 Aug 24 | CAVA CAVA | Common Stock | Sell | Dispose S | No | No | 116.36 | 6,000,000 | 698.16 mm | 17,507,990 |
5 Jun 24 | CAVA CAVA | Common Stock | Sell | Dispose S | No | No | 87.25 | 3,000,000 | 261.75 mm | 23,507,990 |
10 May 24 | LXRX Lexicon Pharmaceuticals | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 57,546,100 | 0.00 | 136,180,481 |
10 May 24 | LXRX Lexicon Pharmaceuticals | Series A Convertible Preferred Stock Common Stock | Option exercise | Dispose M | Yes | No | 0 | 1,150,922 | 0.00 | 0 |
10 May 24 | LXRX Lexicon Pharmaceuticals | Series A Convertible Preferred Stock Common Stock | Grant | Acquire A | Yes | No | 108.5 | 1,150,922 | 124.88 mm | 1,150,922 |
21 Mar 24 | CAVA CAVA | Common Stock | Sell | Dispose S | No | No | 66.25 | 2,000,000 | 132.50 mm | 26,507,990 |